|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 644.36 USD | -1.05% |
|
-5.22% | -16.63% |
| 07-22 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 07-21 | Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Regeneron Pharmaceuticals, Inc.
| 2026-05-19 | Quarterly 0.94 USD |
| 2026-02-19 | Quarterly 0.94 USD |
| 2025-11-19 | Quarterly 0.88 USD |
| 2025-08-17 | Quarterly 0.88 USD |
| 2025-05-19 | Quarterly 0.88 USD |
| 2025-02-19 | Quarterly 0.88 USD |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
